Acquiring Company
AstraZeneca Plc
Acquired Company
Bristol Myers Squibb
Cambridge
LawrencevilleBiotechnologyHealth CarePharmaceuticalBiopharmaManufacturingBiotechnologyProfessional ServicesHealth CareMedicalTherapeuticsPharmaceuticalLegalBiopharmaLaw EnforcementDescription
AstraZeneca and Bristol Myers Squibb are engaged in discussions for a potential $400 billion merger. The deal would create the fourth-largest pharmaceutical company globally but faces significant regulatory hurdles and uncertainty. Analysts suggest that the merger may involve a combination of cash and stock, with both companies citing operational synergies. Market concerns about patent expirations and regulatory scrutiny from antitrust authorities remain critical considerations.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment AstraZeneca Plc makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Trusted by
M&A Insights
Based on deal dataFrequently asked
Who acquired Bristol Myers Squibb?
Bristol Myers Squibb was acquired by AstraZeneca Plc, based in Cambridge. The deal was reported on September 19, 2026. AstraZeneca is a global, science-led biopharmaceutical company. It focuses on the discovery, development, and commercialization of prescription medicines. AstraZeneca Plc is privately held and operates in Biotechnology.
When did AstraZeneca Plc acquire Bristol Myers Squibb?
AstraZeneca Plc's acquisition of Bristol Myers Squibb was reported on September 19, 2026. AstraZeneca and Bristol Myers Squibb are engaged in discussions for a potential $400 billion merger. The deal would create the fourth-largest pharmaceutical company globally but faces significant regulatory hurdles and uncertainty. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Bristol Myers Squibb do?
Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. It is publicly traded (BMY), operating in Manufacturing, and is based in Lawrenceville.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.
5 screens from a live account. No signup.